The End of Alzheimer's: The First Programme to Prevent and Reverse the Cognitive Decline of Dementia
"The End of Alzheimer's is a phenomenal book. Dr Dale Bredesen's research is some of the most exciting work that I have seen in years and tackles the most important health issue of our time. It helps us understand this complex and devastating condition but is also the roadmap to prevent it in the first place. By tackling arguably the most important disease of our age, Dr Dale Bredesen is actually changing the way we look at all chronic disease. This is a masterpiece and a must-read book." * Dr Rangan Chatterjee * "The End of Alzheimer's is a monumental work. Dr Bredesen completely recontextualizes this devastating condition away from a mysterious and unsolvable process to one that is both preventable and, yes, reversible." * David Perlmutter, MD, author, #1 New York Times best seller, Grain Brain, and Brain Maker * "The End of Alzheimer's is a masterful, authoritative, and ultimately hopeful patient guide that will help you prevent and reverse Alzheimer's disease, whether you have the ApoE4 gene or not. My patients fear Alzheimer's more than any other diagnosis. This is the book to transmute fear into action." * Sara Gottfried, MD, author of the New York Times best seller Younger * "Dr Dale Bredesen is a world-class neuroscientist/neurologist who through his innovative and exacting research has discovered a safe and effective approach to the prevention and treatment of Alzheimer's disease that will revolutionize the way we think about the disease." * Jeffrey Bland, PhD, Founder of the Institute for Functional Medicine * "Dr Bredesen has provided enormous hope for the heretofore intractable clinical problem of Alzheimer's. Bredesen's early studies suggest that this approach can halt and in many cases reverse early Alzheimer's." * Leroy Hood, MD, PhD, Winner of the National Medal of Science from President Barack Obama, and Founder, Institute for Systems Biology *
Dale Bredesen, MD, is internationally recognised as an expert in the mechanisms of neurodegenerative diseases, such as Alzheimer's disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr Bredesen directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as its founding president and CEO. He is Professor of Neurology at the University of California, Los Angeles.